Cartesian Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-11.9M | $-12.3M | $455.0K | $2.8M |
| Jun 2022 | $-12.3M | $-12.4M | $99.0K | $3.6M |
| Sep 2022 | $4.4M | $3.9M | $436.0K | $2.6M |
| Dec 2022 | $-11.8M | $-12.1M | $211.0K | $2.3M |
| Mar 2023 | $-8.8M | $-8.9M | $130.0K | $2.3M |
| Jun 2023 | $-9.9M | $-9.9M | $12.0K | $3.8M |
| Sep 2023 | $-9.2M | $-9.2M | $0 | $2.3M |
| Dec 2023 | $-23.3M | $-23.4M | $64.0K | $14.1M |
| Mar 2024 | $-15.9M | $-16.5M | $602.0K | $1.4M |
| Jun 2024 | $-14.4M | $-16.0M | $1.6M | $1.6M |
| Sep 2024 | $13.7M | $7.5M | $6.2M | $1.7M |
| Dec 2024 | $-7.0M | $-7.7M | $705.0K | $1.9M |
| Mar 2025 | $-23.1M | $-24.2M | $1.1M | $2.5M |
| Jun 2025 | $-17.5M | $-20.1M | $2.6M | $3.3M |
| Sep 2025 | $-15.6M | $-16.9M | $1.3M | $2.6M |
| Dec 2025 | $-17.7M | $-18.2M | $492.0K | $2.1M |
| Mar 2026 | $-22.1M | $-22.2M | $27.0K | $2.4M |
| Jun 2026 | $-21.1M | $-21.4M | $272.0K | $2.1M |